# APOBEC3B regulates HPV replication by inducing R-loop formation and DNA damage

**Authors:** Conor W. Templeton, Jasmine S. Gulik, Laimonis A. Laimins

PMC · DOI: 10.1371/journal.ppat.1014088 · PLOS Pathogens · 2026-03-23

## TL;DR

APOBEC3B promotes HPV replication by forming R-loops and causing DNA damage, which affects both viral and cellular gene expression.

## Contribution

APOBEC3B is shown to regulate R-loop formation and DNA damage in HPV-positive cells, acting as a proviral factor.

## Key findings

- APOBEC3B binds to HPV and cellular chromatin, inducing R-loop formation and DNA damage.
- Depletion of APOBEC3B reduces R-loops and DNA breaks while altering immune gene expression.
- APOBEC3B regulates viral replication and gene expression in HPV-positive cells.

## Abstract

APOBECs are cytidine deaminases whose levels are increased in cells with high-risk HPV genomes and are responsible for most mutations in HPV associated cancers. APOBEC3B is a nuclear member of this family and is shown to be a positive regulator of HPV replication as well as expression. The proviral effects of A3B found in HPV positive cells contrast with its role as a restriction factor for many other viruses. Studies demonstrated that A3B can bind and regulate the formation of R-loops, which are trimeric nucleic acid structures consisting of an RNA paired with its complementary DNA strand, displacing one of the DNA strands. The present study demonstrates that A3B binds stably to both cellular and viral chromatin at sequences containing high R-loop levels, including the HPV URR and early polyadenylation sites. Importantly, A3B was found to play a critical role in the replication of HPV genomes and in regulating viral expression. Reduction of R-loop levels through overexpression of the R-loop specific RNase, RNase H1, impaired A3B binding to viral genomes as well as at multiple cellular sites. When A3B was depleted, total R-loop levels decreased by ~50%, leading to impaired viral transcription and an increase in the expression of immune genes, such as OASL, IL6, and IRF1. Mapping R-loop formation in A3B depleted cells revealed that A3B regulated a subset of R-loops that form on the transcriptional start (TSS) and termination sites (TTS) of cellular genes, including at the HPV URR. Furthermore, A3B depletion resulted in over a 50% reduction of DNA breaks along with altered expression of DNA damage repair proteins. This study demonstrates that A3B is an inducer of R-loop formation and DNA damage in HPV positive cells, thereby regulating cellular and viral gene expression along with HPV replication.

The APOBEC3 (A3) family of proteins plays a significant role in the generation of mutations in the development of HPV positive cancers. A3 levels are increased in HPV positive cancers that often contain only integrated copies of the HPV genome, as well as in precancerous lesions that contain viral episomes, but little is known about their role in viral pathogenesis. In this study, A3B, one of the cytosine deaminases within the A3 family, was found to be present at high levels in cells that maintain viral episomes, and these elevated levels were shown to be crucial for viral DNA maintenance and gene expression. This is in contrast to A3B’s role as a restriction factor during the life cycle of other DNA viruses. Increased A3B expression in HPV positive cells induced R-loop formation as well as DNA damage, which was important for regulating the expression of a subset of cellular genes. In addition, many, but not all, of the R-loops within HPV positive cells are bound by A3B, including those on the viral URR and early polyA site. Knockdown of A3B reduced R-loop formation at the URR, and similar effects were observed on cellular genes, altering their expression. These data indicate that A3B acts as a proviral factor in HPV replication by regulating R-loop formation and cellular and viral gene expression.

## Linked entities

- **Genes:** APOBEC3B (apolipoprotein B mRNA editing enzyme catalytic subunit 3B) [NCBI Gene 9582], OASL (2'-5'-oligoadenylate synthetase like) [NCBI Gene 8638], IL6 (interleukin 6) [NCBI Gene 3569], IRF1 (interferon regulatory factor 1) [NCBI Gene 3659]
- **Proteins:** APOBEC3B (apolipoprotein B mRNA editing enzyme catalytic subunit 3B), RNASEH1 (ribonuclease H1)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** IL-10 [NCBI Gene 100136835], APOBEC3F (apolipoprotein B mRNA editing enzyme catalytic subunit 3F) [NCBI Gene 200316] {aka A3F, ARP8, BK150C2.4.MRNA, KA6}, IRF1 (interferon regulatory factor 1) [NCBI Gene 3659] {aka IMD117, IRF-1, MAR}, ATR (ATR checkpoint kinase) [NCBI Gene 545] {aka FCTCS, FRP1, MEC1, SCKL, SCKL1}, APOBEC3B (apolipoprotein B mRNA editing enzyme catalytic subunit 3B) [NCBI Gene 9582] {aka A3B, APOBEC1L, ARCD3, ARP4, DJ742C19.2, PHRBNL}, ATM (ATM serine/threonine kinase) [NCBI Gene 472] {aka AT1, ATA, ATC, ATD, ATDC, ATE}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, SNRPN (small nuclear ribonucleoprotein polypeptide N) [NCBI Gene 6638] {aka HCERN3, PWCR, RT-LI, SM-D, SMN, SNRNP-N}, MYADM (myeloid associated differentiation marker) [NCBI Gene 91663] {aka SB135}, OASL (2'-5'-oligoadenylate synthetase like) [NCBI Gene 8638] {aka OASL1, OASLd, TRIP-14, TRIP14, p59 OASL, p59-OASL}, p53 [NCBI Gene 100136737], IFI44 (interferon induced protein 44) [NCBI Gene 10561] {aka MTAP44, TLDC5, p44}, APOBEC3A (apolipoprotein B mRNA editing enzyme catalytic subunit 3A) [NCBI Gene 200315] {aka A3A, ARP3, PHRBN, bK150C2.1}, EP400 (E1A binding protein p400) [NCBI Gene 57634] {aka CAGH32, P400, TNRC12}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IRF1 [NCBI Gene 100135950], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, RAD51 (RAD51 recombinase) [NCBI Gene 5888] {aka BRCC5, FANCR, HRAD51, HsRad51, HsT16930, MRMV2}, ISG15 (ISG15 ubiquitin like modifier) [NCBI Gene 9636] {aka G1P2, IFI15, IMD38, IP17, UCRP, hUCRP}, RNASEH1 (ribonuclease H1) [NCBI Gene 246243] {aka H1RNA, PEOB2, RNH1}, APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic subunit 3G) [NCBI Gene 60489] {aka A3G, ARCD, ARP-9, ARP9, CEM-15, CEM15}, RPL13A (ribosomal protein L13a) [NCBI Gene 23521] {aka L13A, TSTA1, uL13}, EGR1 (early growth response 1) [NCBI Gene 1958] {aka AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268}, APOB (apolipoprotein B) [NCBI Gene 338] {aka FCHL2, FLDB, LDLCQ4, apoB-100, apoB-48}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, SETX (senataxin) [NCBI Gene 23064] {aka ALS4, AOA2, SCAN2, SCAR1, STEX, Sen1}
- **Diseases:** squamous cell carcinomas of the cervix and oropharynx (MESH:D002294), Precancerous (MESH:D011230), CMV (MESH:D003586), oropharyngeal cancers (MESH:D009959), Skin Disease (MESH:D012871), cervical cancers (MESH:D002583), cancer (MESH:D009369), viral infections (MESH:D014777), HPV infection (MESH:D030361), infections (MESH:D007239), HSV (MESH:D006561)
- **Chemicals:** Laemmli buffer (MESH:C088816), water (MESH:D014867), Trizol (MESH:C411644), EDTA (MESH:D004492), puromycin (MESH:D011691), agar (MESH:D000362), NaOH (MESH:D012972), DAPI (MESH:C007293), SDS (MESH:D012967), HCl (MESH:D006851), paraformaldehyde (MESH:C003043), sodium citrate (MESH:D000077559), ampicillin (MESH:D000667), cytosine (MESH:D003596), ATP (MESH:D000255), uracil (MESH:D014498), EtOH (MESH:D000431), penicillin (MESH:D010406), Lipofectamine 2000 (MESH:C086724), E (MESH:D004540), Methylene blue (MESH:D008751), PBS (MESH:D007854), Phenol (MESH:D019800), 32P (MESH:C000615311), Chloroform (MESH:D002725), formaldehyde (MESH:D005557), TE (MESH:D013691), streptomycin (MESH:D013307), mitomycin (MESH:D016685), poly (A) (MESH:D011061), Cytiva (-), agarose (MESH:D012685)
- **Species:** Papillomaviridae (family) [taxon 151340], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Homo sapiens (human, species) [taxon 9606], Human betaherpesvirus 5 (no rank) [taxon 10359], Escherichia coli (E. coli, species) [taxon 562], Hepatitis B virus (no rank) [taxon 10407], Human immunodeficiency virus 1 (no rank) [taxon 11676], Human immunodeficiency virus (species) [taxon 12721], Human gammaherpesvirus 8 (no rank) [taxon 37296]
- **Mutations:** glycine for 5, C-to-T, H for 2-3
- **Cell lines:** 3T3 J2 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_W667), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), HFK — Homo sapiens (Human), Finite cell line (CVCL_9U04), CIN612 9E — Homo sapiens (Human), Cervical intraepithelial neoplasia, Transformed cell line (CVCL_ER27), CIN 612 — Homo sapiens (Human), Cervical intraepithelial neoplasia, Transformed cell line (CVCL_ER24), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), J2 — Homo sapiens (Human), Transformed cell line (CVCL_N185)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13035229/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13035229/full.md

## References

74 references — full list in the complete paper: https://tomesphere.com/paper/PMC13035229/full.md

---
Source: https://tomesphere.com/paper/PMC13035229